Study/

Year

Study Design

Subject Sources/

Diagnosis

Treatment of Interest

Treatment Frequency

Number of Subjects

Outcome Measures

Follow-Up

Results

Reference [1] /1999

Quasiexperimental.

No blinding, control group(s), or randomization

Vulval clinic/

vulvodynia

Acupuncture Spleen meridian points 6 & 9, liver meridian point 3, large intestine meridian point 4

Once weekly for 10 weeks

12 women aged 18 - 68 years; all completed treatment

VAS pain score (range not given) and adapted QOL questionnaire scores

5 weeks after last treatment session

Three groups of subject response: good, short-term, and non-responders

Reference [17] /2001

Quasiexperimental.

No blinding, control group(s), or randomization

Adolescent health center/

vestibulitis

Acupuncture 4 local and 2 distal points were always used, an additional 2 - 5 points couldalso be used

Once or twice weekly for 10 treatments in total

14 women aged 19 - 26 years; 13 completed treatment

VAS pain score of 0-10, negative/positive QOL questionnaire

11 subjects at 3 months after last treatment session

Statistically significant changes to negative and positive QOL factors p = 0.01 and p = 0.001

Reference [3] /2009

Quasiexperimental No blinding, control group(s), or randomization

Gynecology clinic /provoked vestibulodynia

Acupuncture 10-20 points from the forehead to the knees

Twice weekly for 10 treatments in 5 weeks

8 women aged 21 - 49 years. Mean age 30 years.

FSFI, PCS, PVAQ, and investigator developed pain report

None

Statistically significant improvement in pain with manual genital stimulation on the FSFI, p = 0.05

Reference [12] /1995

Quasiexperimental No blinding, control group(s), or randomization

Vulval clinic/vulvar vestibulitis

EMG biofeedback In-home pelvic floor muscle exercises with vaginal sensor, portable EMG biofeedback instrument, computerized EMG data acquisition

Twice daily for an average of 16 weeks

33women aged 21 - 45 years. Mean age 31.5 years.

Subjective pain scale of 0-10, frequency of coitus, EMG amplitude for contraction, relaxation, and rest periods

6 months

Decreased resting pelvic muscle tension and instability by 68% and 62%. Decreased subjective pain by 83%. Coitus resumed by 78% of abstainers

Reference [8] /2001

Block randomization. Non-blinded. Control groups of group cognitive behavior therapy, vestibulectomy

Media advertisement and referrals/

dyspareunia due to vulvar vestibulitis

EMG biofeedback In-home pelvic floor muscle exercises with vaginal sensor, portable EMG home trainer, computerized EMG data acquisition

Twice daily for 12 weeks

29 per group.

Mean age 26.8 years. Total of 9 subjects overall discontinued

PRI and sensory scales of the McGill Pain Questionnaire, frequency of coitus, Derogatis Sexual Functioning Inventory, Brief Symptom Inventory

6 months

Intention-to-treat analysis statistically significant pain reduction in each group, greatest in vestibulectomy group.

Reference [22] /2001

Quasiexperimental No blinding, control group(s), or randomization

Clinic/vulvar vestibulitis

EMG biofeedback In-home pelvic floor muscle exercises with vaginal sensor, portable EMG home trainer, computerized EMG data acquisition

Twice daily for 11 months

29 women aged 25 - 48 years

Subjective pain scale of 0 - 10 for assessment of dyspareunia. EMG amplitude for contraction and relaxation

None

Significant decrease in pain for 84.7% of subjects. Coitus resumed by 69% of subjects

Reference [23] /2006

Joint computer generated randomization, control group given 2% topical lidocaine gel and 5% lidocaine ointment

Two vulvar clinics/vulvar vestibulitis

EMG biofeedback In-home pelvic floor muscle exercises with vaginal sensor, portable EMG home trainer, computerized EMG data acquisition

Twice daily for 4 months

23 women per group

Negative/positive QOL questionnaire, PRIME MD, Short Form 36, VAS 0 - 100 pain scale, Vulvar pressure pain threshold measured by vulvar algesiometer calibrated for 3 - 1000 grams force

6 and 12 months

Equivalent improvement in vestibular pressure pain thresholds, QOL, and coitus were achieved by each treatment group.